Literature DB >> 1750193

Nuclear DNA content in 27 pancreatic endocrine tumours: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain.

C Donow1, H Baisch, P U Heitz, G Klöppel.   

Abstract

Paraffin-embedded tissue from resection specimens of 14 functioning and 13 nonfunctioning pancreatic endocrine tumours (PET) was analysed for nuclear DNA content by image cytometry. Data on follow-up (mean 5.5 years) were available in all patients. DNA histograms with a diploid pattern were found in 13 (48%) tumours, while an aneuploid pattern was seen in the remaining 14 tumours (52%). Six (40%) of the diploid tumours and 9 (60%) of the aneuploid tumours were malignant. Survival was shorter in patients with malignant and aneuploid PET (mean 3.5 years, range 0.5-7) than in those with malignant and diploid PET (mean 5.7 years, range 3-8). Human chorionic gonadotropin-alpha was expressed in 3 of 12 benign PET, with 1 being aneuploid, and 6 of 15 malignant PET, with 4 being aneuploid. We conclude from these results that the ploidy pattern of PET allows no discrimination between benign and malignant tumours but may provide prognostic information on the aggressiveness of malignant PET.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750193     DOI: 10.1007/bf01650673

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  29 in total

1.  Nuclear DNA analysis of insulinomas and gastrinomas.

Authors:  F Stipa; M Arganini; M Bibbo; F Straus; H Dytch; G Wied; K Horvath; E L Kaplan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

Review 2.  The gastroenteropancreatic endocrine system and related tumors.

Authors:  E Solcia; C Capella; R Fiocca; M Cornaggia; F Bosi
Journal:  Gastroenterol Clin North Am       Date:  1989-12       Impact factor: 3.806

3.  Cellular DNA profiles of benign and malignant adrenocortical tumors.

Authors:  E S Cibas; L J Medeiros; D S Weinberg; A B Gelb; L M Weiss
Journal:  Am J Surg Pathol       Date:  1990-10       Impact factor: 6.394

Review 4.  Cytophotometry in tumor pathology. A critical review of methods and applications, and some results of DNA analysis.

Authors:  W Mellin
Journal:  Pathol Res Pract       Date:  1990-02       Impact factor: 3.250

5.  Influence of cellular DNA content on survival in advanced ovarian cancer.

Authors:  M L Friedlander; D W Hedley; I W Taylor; P Russell; A S Coates; M H Tattersall
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

6.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

Authors:  D W Hedley; C A Rugg; A B Ng; I W Taylor
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

7.  Nuclear DNA in carcinoid tumours of the lung.

Authors:  T Blöndal; T Arnorsson; A Bengtsson; E Wilander
Journal:  Eur J Respir Dis       Date:  1983-05

8.  Correlation of DNA distribution and cytological differentiation of human cervical carcinomas.

Authors:  A Jakobsen; P Bichel; A Sell
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979

9.  A flow cytometric analysis of 23 carcinoid tumors.

Authors:  H Kujari; H Joensuu; P Klemi; R Asola; E Nordman
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

10.  DNA ploidy in bronchopulmonary carcinoid tumours.

Authors:  D J Jones; P S Hasleton; M Moore
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

View more
  8 in total

Review 1.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  Prognostic criteria in nonfunctioning pancreatic endocrine tumours.

Authors:  S La Rosa; F Sessa; C Capella; C Riva; B E Leone; C Klersy; G Rindi; E Solcia
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

3.  Can malignancy in insulinoma be predicted by the expression patterns of beta 1,6 branching of asparagine-linked oligosaccharides and polysialic acid of the neural cell adhesion molecule?

Authors:  W P Li; P Komminoth; C Zuber; G Klöppel; P U Heitz; J Roth
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

Review 4.  Criteria for malignancy in gastrointestinal endocrine tumors.

Authors:  Cesare Bordi; Tiziana D'Adda; Cinzia Azzoni; Silvia Pizzi; Lorena Bottarelli; Francesca Mormandi; Tommaso Antonetti; Tu Vinh Luong; Guido Rindi
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 5.  Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.

Authors:  Mina Jamali; Runjan Chetty
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

6.  Proliferative Activity in Pancreatic Endocrine Tumors: Association with Function, Metastases, and Survival.

Authors:  Martha R. Clarke; Evan E. Baker; Robert J. Weyant; Lisa Hill; Sally E. Carty
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

7.  Flow and image cytometric study of pancreatic neuroendocrine tumours: frequent DNA aneuploidy and an association with the clinical outcome.

Authors:  K A Alanen; U G Falkmer; P J Klemi; H Joensuu; S Falkmer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Von Hippel-Lindau disease presenting as pancreatic neuroendocrine tumour.

Authors:  S L Mount; D L Weaver; D J Taatjes; W C McKinnon; J C Hebert
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.